Search filters

List of works by Yelena Y Janjigian

Distinct clinical course of EGFR-mutant resected lung cancers: results of testing of 1118 surgical specimens and effects of adjuvant gefitinib and erlotinib

scientific article published in December 2012

Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer.

scientific article published on 9 November 2017

HER2 amplification: a potential mechanism of acquired resistance to EGFR inhibition in EGFR-mutant lung cancers that lack the second-site EGFRT790M mutation

scientific article published on 5 September 2012

Impact on disease-free survival of adjuvant erlotinib or gefitinib in patients with resected lung adenocarcinomas that harbor EGFR mutations

scientific article published on March 2011

Maintained sensitivity to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer recurring after adjuvant erlotinib or gefitinib

scientific article published on 10 August 2011

Regorafenib in Combination with First-Line Chemotherapy for Metastatic Esophagogastric Cancer

scientific article published on 30 September 2019

YES1 amplification is a mechanism of acquired resistance to EGFR inhibitors identified by transposon mutagenesis and clinical genomics.

scientific article published on 6 June 2018

Paulina is supported by:

About Paulina

Help